Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dutch Biotech Creates Blood To Neutralize Southeast Asia Bird Flu Strains

This article was originally published in PharmAsia News

Executive Summary

A Dutch biotechnology firm says it has tested successfully blood it created to neutralize the H5N1 virus based on two major strains found in Vietnam and Indonesia. Crucell said its creation of the specific human monoclonal antibodies could be another way to avoid a feared pandemic of avian influenza. The company said it was able to produce one line of antibodies that neutralized strains found in Hong Kong in 1997, in Vietnam in 2003 and in Indonesia in 2005. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066721

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel